Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Pulmonary Hypertension, October 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 127 articles:
HTML format


 

Single Articles

  1. SINGER JP
    Pulmonary Hypertension and Primary Graft Dysfunction in Lung Transplant Recipients: We Still Have a Long Way to Go.
    Ann Am Thorac Soc. 2017;14:1504-1505.
    Abstract    



  2. SAITO N, Kato S, Saito N, Nakachi T, et al
    Distinction Between Precapillary and Postcapillary Pulmonary Hypertension by the Atrial Volume Ratio on Transthoracic Echocardiography.
    J Ultrasound Med. 2017 Sep 29. doi: 10.1002/jum.14424.
    Abstract    

    Abstract available

  3. WESTERHOF BE, Saouti N, van der Laarse WJ, Westerhof N, et al
    Treatment strategies for the right heart in pulmonary hypertension.
    Cardiovasc Res. 2017;113:1465-1473.
    Abstract    

    Abstract available

  4. DEAN A, Gregorc T, Docherty CK, Harvey KY, et al
    Role of the Aryl Hydrocarbon Receptor in Sugen 5416-induced Experimental Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2017 Sep 28. doi: 10.1165/rcmb.2017-0260.
    Abstract    

    Abstract available

  5. LAUNAY D, Sobanski V, Hachulla E, Humbert M, et al
    Pulmonary hypertension in systemic sclerosis: different phenotypes.
    Eur Respir Rev. 2017;26.
    Abstract    

    Abstract available

  6. JONE PN, Schafer M, Pan Z, Bremen C, et al
    3D echocardiographic evaluation of right ventricular function and strain: a prognostic study in paediatric pulmonary hypertension.
    Eur Heart J Cardiovasc Imaging. 2017 Aug 25. doi: 10.1093.
    Abstract    

    Abstract available

  7. AGRAWAL H, Petit CJ, Miro J, Miranda CD, et al
    Contralateral Pulmonary Hypertension Following Resuscitation of Unilateral Ductal Origin of a Pulmonary Artery: A Multi-institutional Review.
    Pediatr Cardiol. 2017 Sep 25. doi: 10.1007/s00246-017-1729.
    Abstract    

    Abstract available

  8. SAHAY S, Khirfan G, Tonelli AR
    Management of combined pre- and post-capillary pulmonary hypertension in advanced heart failure with reduced ejection fraction.
    Respir Med. 2017;131:94-100.
    Abstract    

    Abstract available

  9. PARTHVI R, Sikachi RR, Agrawal A, Adial A, et al
    Pulmonary hypertension associated with antiphospholipid antibody: Call for a screening tool?
    Intractable Rare Dis Res. 2017;6:163-171.
    Abstract    

    Abstract available

  10. KASAI H, Tanabe N, Fujimoto K, Hoshi H, et al
    Mosaic attenuation pattern in non-contrast computed tomography for the assessment of pulmonary perfusion in chronic thromboembolic pulmonary hypertension.
    Respir Investig. 2017;55:300-307.
    Abstract    

    Abstract available

  11. RAZA F, Dillane C, Mirza A, Brailovsky Y, et al
    Differences in right ventricular morphology, not function, indicate the nature of increased afterload in pulmonary hypertensive subjects with normal left ventricular function.
    Echocardiography. 2017 Sep 24. doi: 10.1111/echo.13699.
    Abstract    

    Abstract available

  12. ADIR Y, Guazzi M, Offer A, Temporelli PL, et al
    Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities.
    Am Heart J. 2017;192:120-127.
    Abstract    

    Abstract available

  13. GHOULEH IA, Sahoo S, Meijles DN, Amaral JH, et al
    Endothelial Nox1 oxidase assembly in human pulmonary arterial hypertension; driver of Gremlin1-mediated proliferation.
    Clin Sci (Lond). 2017;131:2019-2035.
    Abstract    

    Abstract available

  14. CASTRO EC, Sen P, Parks WT, Langston C, et al
    The Role of Serotonin Transporter in Human Lung Development and in Neonatal Lung Disorders.
    Can Respir J. 2017;2017:9064046.
    Abstract    

    Abstract available

  15. HE Y, Liu L, Xu P, He N, et al
    Association between single nucleotide polymorphisms in ADRB2, GNB3 and GSTP1 genes and high-altitude pulmonary edema (HAPE) in the Chinese Han population.
    Oncotarget. 2017;8:18206-18212.
    Abstract    

    Abstract available

  16. AMIN A, Mohamadifar A, Keshmiri MS, Ghadrdoost B, et al
    A simple hemodynamic parameter to predict clinical worsening in pulmonary arterial hypertension.
    J Crit Care. 2017;38:324-327.
    Abstract    

    Abstract available

  17. SANGES S, Desauw C, de Groote P, Fertin M, et al
    [Tolerance of bevacizumab therapy in systemic sclerosis-associated pulmonary arterial hypertension: A case report].
    Rev Med Interne. 2017;38:274-277.
    Abstract    

    Abstract available

  18. GROSSE A, Grosse C, Lang IM
    Distinguishing Chronic Thromboembolic Pulmonary Hypertension From Other Causes of Pulmonary Hypertension Using CT.
    AJR Am J Roentgenol. 2017 Oct 5:1-11. doi: 10.2214/AJR.17.17871.
    Abstract    

    Abstract available

  19. FRIESEN RM, Schafer M, Burkett DA, Cassidy CJ, et al
    Right Ventricular Tissue Doppler Myocardial Performance Index in Children with Pulmonary Hypertension: Relation to Invasive Hemodynamics.
    Pediatr Cardiol. 2017 Oct 4. doi: 10.1007/s00246-017-1733.
    Abstract    

    Abstract available

  20. GHOFRANIHA L, Mirfeizi Z, Khabbaz FS, Vakilian F, et al
    Correlation of echocardiographic findings of pulmonary hypertension with six-minute walk test and plasma pro b-type natriuretic peptide level in systemic lupus erythematous.
    Electron Physician. 2017;9:5122-5128.
    Abstract    

    Abstract available

  21. LOPES AA, Thomaz AM
    When to Operate on Pediatric Patients with Congenital Heart Disease and Pulmonary Hypertension.
    Arq Bras Cardiol. 2017;109:183-184.
    Abstract    



  22. KUCUKOGLU S, Sinan UY
    [Pulmonary hypertension in the elderly].
    Turk Kardiyol Dern Ars. 2017;45.
    Abstract    

    Abstract available

  23. BERNIER M, Jacob A, Collaco MJ, McGrath-Morrow S, et al
    EXPRESS: Perioperative Events in Children with Pulmonary Hypertension Undergoing Non-cardiac Procedures.
    Pulm Circ. 2017 Jan 1:2045893217738143. doi: 10.1177/2045893217738143.
    Abstract    



  24. KUMAR A, Neema PK
    Severe pulmonary hypertension and right ventricular failure.
    Indian J Anaesth. 2017;61:753-759.
    Abstract    

    Abstract available

  25. ZHANG Z, Zhang L, Sun C, Kong F, et al
    Baicalin attenuates monocrotaline-induced pulmonary hypertension through bone morphogenetic protein signaling pathway.
    Oncotarget. 2017;8:63430-63441.
    Abstract    

    Abstract available

  26. MINATSUKI S, Hatano M, Maki H, Ando J, et al
    The Structure of a Chronic Total Occlusion and Its Safe Treatment in a Patient with Chronic Thromboembolic Pulmonary Hypertension.
    Int Heart J. 2017 Sep 30. doi: 10.1536.
    Abstract    

    Abstract available

  27. KAMENSKAYA O, Klinkova A, Loginova I, Chernyavskiy A, et al
    Factors affecting the quality of life before and after surgery in patients with chronic thromboembolic pulmonary hypertension.
    Qual Life Res. 2017 Sep 30. doi: 10.1007/s11136-017-1712.
    Abstract    

    Abstract available

  28. YINGCHONCHAROEN T, Rakyhao T, Chuncharunee S, Sritara P, et al
    Inhaled nebulized sodium nitrite decreases pulmonary artery pressure in beta-thalassemia patients with pulmonary hypertension.
    Nitric Oxide. 2017 Sep 27. pii: S1089-8603(17)30216.
    Abstract    

    Abstract available

  29. HOSOKAWA K, Abe K, Kashihara S, Tsutsui H, et al
    3-Dimensional SPECT/CT Fusion Imaging-Guided Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.
    JACC Cardiovasc Interv. 2017 Sep 19. pii: S1936-8798(17)31625.
    Abstract    



  30. RONG H, He X, Zhu L, Zhu X, et al
    Association between regulator of telomere elongation helicase1 (RTEL1) gene and HAPE risk: A case-control study.
    Medicine (Baltimore). 2017;96:e8222.
    Abstract    

    Abstract available

  31. ZHAI Z, Zhou X, Zhang S, Xie W, et al
    The impact and financial burden of pulmonary arterial hypertension on patients and caregivers: results from a national survey.
    Medicine (Baltimore). 2017;96:e6783.
    Abstract    

    Abstract available

  32. STEPNOWSKA E, Lewicka E, Dabrowska-Kugacka A, Miekus P, et al
    Prognostic factors in pulmonary arterial hypertension: Literature review.
    Adv Clin Exp Med. 2017;26:549-553.
    Abstract    

    Abstract available

  33. GEORGESCU AM, Moldovan C, Szederjesi J, Georgescu D, et al
    Echocardiographic characteristics of pulmonary arterial hypertension in children with horizontally transmitted HIV.
    Adv Clin Exp Med. 2017;26:475-481.
    Abstract    

    Abstract available

  34. SIMON C, Allou N, Schlossmacher P, Gendry T, et al
    [Lung transplantation in Reunion Island, current situation from January 2005 till May 2015].
    Rev Pneumol Clin. 2017;73:75-80.
    Abstract    

    Abstract available

  35. WANG JK, Chiu SN, Lin MT, Chen CA, et al
    Mid-to-long-term follow-up results of transcatheter closure of atrial septal defect in patients older than 40 years.
    Heart Vessels. 2017;32:467-473.
    Abstract    

    Abstract available

  36. SCARDULLA F, Bellavia D, Vitulo P, Romano G, et al
    Biomechanical Determinants of Right Ventricular Failure in Pulmonary Hypertension.
    ASAIO J. 2017 Oct 11. doi: 10.1097/MAT.0000000000000683.
    Abstract    

    Abstract available

  37. AMINDE LN, Dzudie A, Kenge AP, Ndjebet J, et al
    Gender disparities in pulmonary hypertension at a tertiary centre in Cameroon.
    S Afr Med J. 2017;107:892-899.
    Abstract    

    Abstract available

  38. MOREIRA-GONCALVES D, Ferreira-Nogueira R, Santos M, Silva AF, et al
    Exercise Training in Pulmonary Hypertension and Right Heart Failure: Insights from Pre-clinical Studies.
    Adv Exp Med Biol. 2017;999:307-324.
    Abstract    

    Abstract available

  39. LUSCHER TF
    Special issues in heart failure: pulmonary hypertension, deranged potassium levels, and haemodynamic profiles.
    Eur Heart J. 2017;38:2857-2859.
    Abstract    



  40. BALIEVA I, Dzudie A, Thienemann F, Mocumbi AO, et al
    Prevalence and predictive value of electrocardiographic abnormalities in pulmonary hypertension: evidence from the Pan-African Pulmonary Hypertension Cohort (PAPUCO) study.
    Cardiovasc J Afr. 2017;28:1-7.
    Abstract    

    Abstract available

  41. KAMOLVISIT W, Jaroensri S, Ratchatapantanakorn B, Nakwan N, et al
    Factors and Outcomes of Persistent Pulmonary Hypertension of the Newborn Associated with Acute Kidney Injury in Thai Neonates.
    Am J Perinatol. 2017 Oct 10. doi: 10.1055/s-0037-1607213.
    Abstract    



  42. HUMBERT M, Singh M, Furst DE, Khanna D, et al
    Pulmonary hypertension related to systemic sclerosis: points to consider for clinical trials.
    Rheumatology (Oxford). 2017;56.
    Abstract    

    Abstract available

  43. GYONGYOSI M, Pavo N, Lukovic D, Zlabinger K, et al
    Porcine model of progressive cardiac hypertrophy and fibrosis with secondary postcapillary pulmonary hypertension.
    J Transl Med. 2017;15:202.
    Abstract    

    Abstract available

  44. KORMAN BD, Marangoni RG, Hinchcliff M, Shah SJ, et al
    Brief Report: Association of Elevated Adipsin Levels With Pulmonary Arterial Hypertension in Systemic Sclerosis.
    Arthritis Rheumatol. 2017;69:2062-2068.
    Abstract    

    Abstract available

  45. SADE LE, Kozan H, Eroglu S, Pirat B, et al
    Three-Dimensional Right Ventricular Strain Versus Volume Quantification in Heart Transplant Recipients in Relation to Pulmonary Artery Pressure.
    Exp Clin Transplant. 2017;15.
    Abstract    

    Abstract available

  46. ZUK M, Migdal A, Jagiellowicz-Kowalska D, Mazurkiewicz K, et al
    Six-Minute Walk Test in Evaluation of Children with Pulmonary Arterial Hypertension.
    Pediatr Cardiol. 2017;38:754-761.
    Abstract    

    Abstract available

  47. RIGBY ML, Rosenthal M
    Cardiorespiratory Interactions in Paediatrics: 'It's (almost always) the circulation stupid!'
    Paediatr Respir Rev. 2017;22:60-65.
    Abstract    

    Abstract available

  48. MA L, Zhou P, Neu J, Lin HC, et al
    Potential Nutrients for Preventing or Treating Bronchopulmonary Dysplasia.
    Paediatr Respir Rev. 2017;22:83-88.
    Abstract    

    Abstract available

  49. FEDERICO A, Zappavigna S, Dallio M, Misso G, et al
    Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive Tract Cancers and other Tumors.
    Curr Cancer Drug Targets. 2017;17:109-121.
    Abstract    

    Abstract available

  50. YU Q, Chan SY
    Mitochondrial and Metabolic Drivers of Pulmonary Vascular Endothelial Dysfunction in Pulmonary Hypertension.
    Adv Exp Med Biol. 2017;967:373-383.
    Abstract    

    Abstract available

  51. SURESH K, Shimoda LA
    Endothelial Cell Reactive Oxygen Species and Ca2+ Signaling in Pulmonary Hypertension.
    Adv Exp Med Biol. 2017;967:299-314.
    Abstract    

    Abstract available

  52. SHARMA M, Afolayan AJ
    Redox Signaling and Persistent Pulmonary Hypertension of the Newborn.
    Adv Exp Med Biol. 2017;967:277-287.
    Abstract    

    Abstract available

  53. PLECITA-HLAVATA L, D'alessandro A, El Kasmi K, Li M, et al
    Metabolic Reprogramming and Redox Signaling in Pulmonary Hypertension.
    Adv Exp Med Biol. 2017;967:241-260.
    Abstract    

    Abstract available

  54. MAARMAN GJ
    Natural Antioxidants as Potential Therapy, and a Promising Role for Melatonin Against Pulmonary Hypertension.
    Adv Exp Med Biol. 2017;967:161-178.
    Abstract    

    Abstract available

  55. JERNIGAN NL, Resta TC, Gonzalez Bosc LV
    Altered Redox Balance in the Development of Chronic Hypoxia-induced Pulmonary Hypertension.
    Adv Exp Med Biol. 2017;967:83-103.
    Abstract    

    Abstract available

  56. JAITOVICH A, Jourd'heuil D
    A Brief Overview of Nitric Oxide and Reactive Oxygen Species Signaling in Hypoxia-Induced Pulmonary Hypertension.
    Adv Exp Med Biol. 2017;967:71-81.
    Abstract    

    Abstract available

  57. HASHIMOTO R, Gupte S
    Pentose Shunt, Glucose-6-Phosphate Dehydrogenase, NADPH Redox, and Stem Cells in Pulmonary Hypertension.
    Adv Exp Med Biol. 2017;967:47-55.
    Abstract    

    Abstract available

  58. EVANS CE, Zhao YY
    Molecular Basis of Nitrative Stress in the Pathogenesis of Pulmonary Hypertension.
    Adv Exp Med Biol. 2017;967:33-45.
    Abstract    

    Abstract available

  59. DI MISE A, Wang YX, Zheng YM
    Role of Transcription Factors in Pulmonary Artery Smooth Muscle Cells: An Important Link to Hypoxic Pulmonary Hypertension.
    Adv Exp Med Biol. 2017;967:13-32.
    Abstract    

    Abstract available

  60. WEATHERALD J, Savale L, Humbert M
    Medical Management of Pulmonary Hypertension with Unclear and/or Multifactorial Mechanisms (Group 5): Is There a Role for Pulmonary Arterial Hypertension Medications?
    Curr Hypertens Rep. 2017;19:86.
    Abstract    

    Abstract available

  61. HOSOKAWA K, Yamamoto T, Abe K, Tsutsui H, et al
    Delayed-onset lung injury after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension-a case report.
    Eur Heart J Cardiovasc Imaging. 2017 Oct 17. doi: 10.1093.
    Abstract    



  62. SCHAFER M, Truong U, Browne LP, Morgan GJ, et al
    Measuring Flow Hemodynamic Indices and Oxygen Consumption in Children with Pulmonary Hypertension: A Comparison of Catheterization and Phase-Contrast MRI.
    Pediatr Cardiol. 2017 Oct 17. doi: 10.1007/s00246-017-1751.
    Abstract    

    Abstract available

  63. LI Y, Wang Y, Li H, Zhu W, et al
    Evaluation of the hemodynamics and right ventricular function in pulmonary hypertension by echocardiography compared with right-sided heart catheterization.
    Exp Ther Med. 2017;14:3616-3622.
    Abstract    

    Abstract available

  64. MOVSISYAN GA, Martynyuk TV, Mershin KV, Danilov NM, et al
    [Chronic thromboembolic pulmonary hypertension developed in a female patient with lupus erythematosus and secondary antiphospholipid syndrome].
    Ter Arkh. 2017;89:93-99.
    Abstract    

    Abstract available

  65. NETO-NEVES EM, Frump AL, Vayl A, Kline JA, et al
    Isolated heart model demonstrates evidence of contractile and diastolic dysfunction in right ventricles from rats with sugen/hypoxia-induced pulmonary hypertension.
    Physiol Rep. 2017;5.
    Abstract    

    Abstract available

  66. MADENCI AL, Church JT, Gajarski RJ, Marchetti K, et al
    Pulmonary Hypertension in Patients with Congenital Diaphragmatic Hernia: Does Lung Size Matter?
    Eur J Pediatr Surg. 2017 Oct 16. doi: 10.1055/s-0037-1607291.
    Abstract    



  67. BUI CB, Pang MA, Sehgal A, Theda C, et al
    Pulmonary hypertension associated with bronchopulmonary dysplasia in preterm infants.
    J Reprod Immunol. 2017;124:21-29.
    Abstract    

    Abstract available

  68. DA SILVA GONCALVES BOS D, Happe C, Schalij I, Pijacka W, et al
    Renal Denervation Reduces Pulmonary Vascular Remodeling and Right Ventricular Diastolic Stiffness in Experimental Pulmonary Hypertension.
    JACC Basic Transl Sci. 2017;2:22-35.
    Abstract    

    Abstract available

  69. BAILLIE TJ, Granton JT
    Lung Transplantation for Pulmonary Hypertension and Strategies to Bridge to Transplant.
    Semin Respir Crit Care Med. 2017;38:701-710.
    Abstract    



  70. FISHER MR, Kim NH
    Chronic Thromboembolic Pulmonary Hypertension: Advances in Therapy.
    Semin Respir Crit Care Med. 2017;38:677-685.
    Abstract    



  71. GERGES M, Gerges C, Naeije R, Lang IM, et al
    Pulmonary Hypertension Due to Left Heart Disease.
    Semin Respir Crit Care Med. 2017;38:662-676.
    Abstract    



  72. VOLKMANN ER, Chung A, Saggar R, Belperio JA, et al
    Pulmonary Hypertension Complicating Connective Tissue Disease.
    Semin Respir Crit Care Med. 2017;38:619-635.
    Abstract    



  73. GUIGNABERT C, Dorfmuller P
    Pathology and Pathobiology of Pulmonary Hypertension.
    Semin Respir Crit Care Med. 2017;38:571-584.
    Abstract    



  74. ALVES-JR JL, Oleas FG, Souza R
    Pulmonary Hypertension: Definition, Classification, and Diagnosis.
    Semin Respir Crit Care Med. 2017;38:561-570.
    Abstract    



  75. HUMBERT M
    Evolving Concepts in Pulmonary Hypertension.
    Semin Respir Crit Care Med. 2017;38:559-560.
    Abstract    



  76. RIVERS-BOWERMAN MD, Zener R, Jaberi A, de Perrot M, et al
    Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension: New Horizons in the Interventional Management of Pulmonary Embolism.
    Tech Vasc Interv Radiol. 2017;20:206-215.
    Abstract    

    Abstract available

  77. SHEMIN RJ
    Surgical Embolectomy for Massive and Submassive Pulmonary Embolism and Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension.
    Tech Vasc Interv Radiol. 2017;20:175-178.
    Abstract    

    Abstract available

  78. AOKI T, Sugimura K, Tatebe S, Miura M, et al
    Comprehensive evaluation of the effectiveness and safety of balloon pulmonary angioplasty for inoperable chronic thrombo-embolic pulmonary hypertension: long-term effects and procedure-related complications.
    Eur Heart J. 2017 Sep 23. doi: 10.1093.
    Abstract    

    Abstract available

  79. SCHUMER EM, Gallo M, Rogers MP, Trivedi JR, et al
    The Development of Pulmonary Hypertension Results in Decreased Post-Transplant Survival.
    ASAIO J. 2017 Oct 10. doi: 10.1097/MAT.0000000000000682.
    Abstract    

    Abstract available

  80. HAN CF, Li ZY, Li TH
    Roles of hypoxia-inducible factor-1alpha and its target genes in neonatal hypoxic pulmonary hypertension.
    Eur Rev Med Pharmacol Sci. 2017;21:4167-4180.
    Abstract    

    Abstract available

  81. RUIGROK D, Symersky P, Elbers PWG, Kamminga S, et al
    [Chronic thromboembolic pulmonary hypertension: recognition, diagnosis and treatment].
    Ned Tijdschr Geneeskd. 2017;161:D1597.
    Abstract    

    Abstract available

  82. CHAIX MA, Dore A, Mercier LA, Mongeon FP, et al
    Late Onset Postcapillary Pulmonary Hypertension in Patients With Transposition of the Great Arteries and Mustard or Senning Baffles.
    J Am Heart Assoc. 2017;6.
    Abstract    

    Abstract available

  83. ZHU R, Chen L, Xiong Y, Wang N, et al
    An upregulation of CD8+CD25+Foxp3+ T cells with suppressive function through interleukin 2 pathway in pulmonary arterial hypertension.
    Exp Cell Res. 2017;358:182-187.
    Abstract    

    Abstract available

  84. DANDOY CE, Jodele S, Paff Z, Hirsch R, et al
    Team-based approach to identify cardiac toxicity in critically ill hematopoietic stem cell transplant recipients.
    Pediatr Blood Cancer. 2017;64.
    Abstract    

    Abstract available

  85. HAN X, Zhang Y, Dong L, Fang L, et al
    Treatment of Pulmonary Arterial Hypertension Using Initial Combination Therapy of Bosentan and Iloprost.
    Respir Care. 2017;62:489-496.
    Abstract    

    Abstract available

  86. FRANZONE A, O'Sullivan CJ, Stortecky S, Heg D, et al
    Prognostic impact of invasive haemodynamic measurements in combination with clinical and echocardiographic characteristics on two-year clinical outcomes of patients undergoing transcatheter aortic valve implantation.
    EuroIntervention. 2017;12:e2186-e2193.
    Abstract    

    Abstract available

  87. MUELLER I, Jansen-Park SH, Neidlin M, Steinseifer U, et al
    Design of a right ventricular mock circulation loop as a test bench for right ventricular assist devices.
    Biomed Tech (Berl). 2017;62:131-137.
    Abstract    

    Abstract available

  88. ALGHANEM F, Bryner BS, Jahangir EM, Fernando UP, et al
    Pediatric Artificial Lung: A Low-Resistance Pumpless Artificial Lung Alleviates an Acute Lamb Model of Increased Right Ventricle Afterload.
    ASAIO J. 2017;63:223-228.
    Abstract    

    Abstract available

  89. PETIT PC, Fine DH, Vasquez GB, Gamero L, et al
    The Pathophysiology of Nitrogen Dioxide During Inhaled Nitric Oxide Therapy.
    ASAIO J. 2017;63:7-13.
    Abstract    

    Abstract available

  90. CROWE T, Jayasekera G, Peacock A
    EXPRESS: Non-invasive Imaging of Global and Regional Cardiac Function in Pulmonary Hypertension.
    Pulm Circ. 2017 Jan 1:2045893217742000. doi: 10.1177/2045893217742000.
    Abstract    



  91. ADUSUMALLI S, Mazurek JA
    Pulmonary Hypertension Due to Left Ventricular Cardiomyopathy: Is it the Result or Cause of Disease Progression?
    Curr Heart Fail Rep. 2017 Oct 23. doi: 10.1007/s11897-017-0368.
    Abstract    

    Abstract available

  92. NAGAYOSHI S, Fujii S, Nakajima T, Muto M, et al
    Intravenous Ultrasound-Guided Balloon Pulmonary Angioplasty in the Treatment of Totally Occluded Chronic Thromboembolic Pulmonary Hypertension.
    EuroIntervention. 2017 Oct 24. pii: EIJ-D-17-00770. doi: 10.4244/EIJ-D-17-00770.
    Abstract    



  93. KARPUZ D, Hallioglu O, Buyukakilli B, Gurgul S, et al
    Clinical and histopathological relationship of sildenafil and bosentan treatments in rats with monocrotaline induced pulmonary hypertension.
    Bratisl Lek Listy. 2017;118:544-551.
    Abstract    

    Abstract available

  94. JASINSKA-STROSCHEIN M, Sztuka K, Orszulak-Michalak D
    [Current issues in etiology, diagnostics and management in pulmonary hypertension].
    Wiad Lek. 2017;70.
    Abstract    

    Abstract available

  95. CORREALE M, Tarantino N, Paradiso G, Monaco I, et al
    Macitentan Use in a Neurofibromatosis Type 1 Patient With Pulmonary Hypertension and External Jugular Phlebectasia.
    Am J Ther. 2017 Oct 20. doi: 10.1097/MJT.0000000000000601.
    Abstract    



  96. DANI C, Corsini I, Cangemi J, Vangi V, et al
    Nitric oxide for the treatment of preterm infants with severe RDS and pulmonary hypertension.
    Pediatr Pulmonol. 2017;52:1461-1468.
    Abstract    

    Abstract available

  97. BABOOA N, Shi WJ, Chen C
    Factors relating caesarean section to persistent pulmonary hypertension of the newborn.
    World J Pediatr. 2017;13:517-527.
    Abstract    

    Abstract available

  98. MIYAZAKI H, Umezu Y, Sato K, Ogawa K, et al
    Reduction Method of Operator and Medical Staff Radiation Exposure in Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.
    Nihon Hoshasen Gijutsu Gakkai Zasshi. 2017;73:1045-1054.
    Abstract    

    Abstract available

  99. SCALONE G, Gomez-Monterrosas O, Fiszer R, Szkutnik M, et al
    Combined strategy of Waterston shunt percutaneous occlusion and medical treatment with sildenafil for management of pulmonary hypertension in an adult patient with corrected tetralogy of Fallot.
    Postepy Kardiol Interwencyjnej. 2017;13:277-278.
    Abstract    



  100. AMADUCCI A, Vitulo P
    [Stenting of multiple peripheral pulmonary stenosis with the coronary technique in an adul patient with Eisenmenger-like syndrome].
    G Ital Cardiol (Rome). 2017;18.
    Abstract    

    Abstract available

  101. FUNKE-CHAMBOUR M, Azzola A, Adler D, Barazzone-Argiroffo C, et al
    Idiopathic Pulmonary Fibrosis in Switzerland: Diagnosis and Treatment.
    Respiration. 2017;93:363-378.
    Abstract    

    Abstract available

  102. GALIE N, Jansa P, Pulido T, Channick RN, et al
    SERAPHIN haemodynamic sub-study: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension.
    Eur Heart J. 2017 Feb 28. doi: 10.1093.
    Abstract    

    Abstract available

  103. PORTA NFM
    Palliative care approaches to neonates with chronic respiratory failure.
    Semin Perinatol. 2017;41:124-127.
    Abstract    

    Abstract available

  104. GUPTA N, Rashid J, Nozik-Grayck E, McMurtry IF, et al
    Cocktail of Superoxide Dismutase and Fasudil Encapsulated in Targeted Liposomes Slows PAH Progression at a Reduced Dosing Frequency.
    Mol Pharm. 2017;14:830-841.
    Abstract    

    Abstract available

  105. MCMAHON TJ, Bryan NS
    Biomarkers in Pulmonary Vascular Disease: Gauging Response to Therapy.
    Am J Cardiol. 2017;120.
    Abstract    

    Abstract available

  106. KLINGER JR, Kadowitz PJ
    The Nitric Oxide Pathway in Pulmonary Vascular Disease.
    Am J Cardiol. 2017;120.
    Abstract    

    Abstract available

  107. VAN DUIN RWB, Houweling B, Uitterdijk A, Duncker DJ, et al
    Pulmonary vasodilation by phosphodiesterase 5-inhibition is enhanced and nitric oxide-independent in early pulmonary hypertension after myocardial infarction.
    Am J Physiol Heart Circ Physiol. 2017 Oct 6:ajpheart.00370.2017.
    Abstract    

    Abstract available

  108. AUSTIN ED, Hamid R
    Y Not? Sex Chromosomes May Modify Sexual Dimorphism in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2017 Oct 2. doi: 10.1164/rccm.201709-1865.
    Abstract    




  109. Pulmonary Hypertension in Children.
    Am J Respir Crit Care Med. 2017;196:P15-P16.
    Abstract    



  110. TALWAR A, Garcia JGN, Tsai H, Moreno M, et al
    Health Disparities in Patients with Pulmonary Arterial Hypertension: A Blueprint for Action. An Official American Thoracic Society Statement.
    Am J Respir Crit Care Med. 2017;196:e32-e47.
    Abstract    

    Abstract available

  111. GROCOTT HP
    Understanding the Significance of Aerosolized Vasodilator Use in Pulmonary Hypertension: What Is Numerically, Statistically, and Clinically Meaningful?
    Anesth Analg. 2017 Sep 25. doi: 10.1213/ANE.0000000000002519.
    Abstract    



  112. HUANG J, Maier C, Zhang Y, Soare A, et al
    Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis.
    Ann Rheum Dis. 2017;76:1941-1948.
    Abstract    

    Abstract available

  113. DONAHOE L, Vanderlaan R, Thenganatt J, McRae K, et al
    Symptoms Are More Useful Than Echocardiography in Patient Selection for Pulmonary Endarterectomy.
    Ann Thorac Surg. 2017 Aug 16. pii: S0003-4975(17)30699.
    Abstract    

    Abstract available

  114. CHADDHA U, Puscas I, Prosper A, Ganesh S, et al
    A 63-Year-Old Woman With Neurofibromatosis Type 1 and Pulmonary Hypertension With Worsening Hypoxemia.
    Chest. 2017;152:e89-e93.
    Abstract    

    Abstract available

  115. ZHANG H, Wang D, Li M, Plecita-Hlavata L, et al
    The Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension is Regulated through a MiR-124/PTBP1/PKM Axis.
    Circulation. 2017 Sep 26. pii: CIRCULATIONAHA.117.028069.
    Abstract    

    Abstract available

  116. ORHAN G, Bastopcu M, Aydemir B, Ersoz MS, et al
    Intracardiac and pulmonary artery hydatidosis causing thromboembolic pulmonary hypertension.
    Eur J Cardiothorac Surg. 2017 Sep 7. doi: 10.1093.
    Abstract    

    Abstract available

  117. BAUGHMAN RP, Shlobin OA
    Treatment of sarcoidosis-associated pulmonary hypertension: so close, and yet so far.
    Eur Respir J. 2017;50.
    Abstract    



  118. DEGANO B, Soumagne T, Delaye T, Berger P, et al
    Combined measurement of carbon monoxide and nitric oxide lung transfer does not improve the identification of pulmonary hypertension in systemic sclerosis.
    Eur Respir J. 2017;50.
    Abstract    

    Abstract available

  119. BOUCLY A, Cottin V, Nunes H, Jais X, et al
    Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension.
    Eur Respir J. 2017;50.
    Abstract    

    Abstract available

  120. MASRI A, Abdelkarim I, Sharbaugh MS, Althouse AD, et al
    Outcomes of persistent pulmonary hypertension following transcatheter aortic valve replacement.
    Heart. 2017 Sep 29. pii: heartjnl-2017-311978. doi: 10.1136/heartjnl-2017-311978
    Abstract    

    Abstract available

  121. KANAAN U, Srivatsa B, Huckaby J, Kelleman M, et al
    Association of unit-wide oxygen saturation target on incidence of pulmonary hypertension in very low birthweight premature infants.
    J Perinatol. 2017 Oct 19. doi: 10.1038/jp.2017.
    Abstract    

    Abstract available

  122. BRAVOS E, Bayle-Bleuez S, Wahart A, Lacheze R, et al
    [A not so poorly-defined opacity].
    Rev Mal Respir. 2017;34:249-252.
    Abstract    

    Abstract available

  123. REVUZ S, Decullier E, Ginon I, Lamblin N, et al
    Pulmonary hypertension subtypes associated with hereditary haemorrhagic telangiectasia: Haemodynamic profiles and survival probability.
    PLoS One. 2017;12:e0184227.
    Abstract    

    Abstract available

  124. JERNIGAN NL, Naik JS, Weise-Cross L, Detweiler ND, et al
    Contribution of reactive oxygen species to the pathogenesis of pulmonary arterial hypertension.
    PLoS One. 2017;12:e0180455.
    Abstract    

    Abstract available

  125. ZUNGU-EDMONDSON M, Shults NV, Melnyk O, Suzuki YJ, et al
    Natural reversal of pulmonary vascular remodeling and right ventricular remodeling in SU5416/hypoxia-treated Sprague-Dawley rats.
    PLoS One. 2017;12:e0182551.
    Abstract    

    Abstract available

  126. LE GOUELLEC N, Duhamel A, Perez T, Hachulla AL, et al
    Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease.
    PLoS One. 2017;12:e0181692.
    Abstract    

    Abstract available

  127. SUGIMOTO K, Nakazato K, Sato A, Suzuki S, et al
    Autoimmune disease mouse model exhibits pulmonary arterial hypertension.
    PLoS One. 2017;12:e0184990.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;